EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Investigation of the status of immune checkpoint molecules (PD-L1 and PD-1) in meningiomas by immunohistochemistry

İsmail Saygin iD, Emel Çakir iD, Seher Nazlı Kazaz iD, Ali Rıza Güvercin iD, İlker Eyüpoğlu iD, Müşerref Müge Ustaoğlu iD

Turkish Journal of Medical Sciences · 23.08.2024 · 54 (4) · 735-743

DOI: 10.55730/1300-0144.5843 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Turkish Journal of Medical Sciences, online erschienen am 23.08.2024. Verfasst von İsmail Saygin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkiye. Hauptthemen laut MEDLINE: Meningioma, B7-H1 Antigen, Meningeal Neoplasms, Immunohistochemistry. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/aim : Meningiomas are the most common primary brain tumors of the central nervous system. Immunotherapy is a promising treatment method applied in many types of cancer. There is no standard and effective medical treatment to reduce recurrence and mortality in cases of incomplete resection of meningiomas and in high-grade cases. In order to investigate medical treatments in addition to surgery and radiotherapy, in this study, the status of immune checkpoint molecules (PD-L1/PD-1), which are the target of immunotherapy, in meningiomas was investigated.Materials and Methods: Four hundred two cases of meningioma diagnosed between 2007 and 2020 in our institution were used. New blocks were prepared from the appropriate blocks of the cases using the tissue microarray method. Sections obtained from these blocks were immunohistochemically stained with PD-1, PD-L1 antibodies. Obtained data were interpreted with statistical analysis.

Results

Expression of PD-L1 was observed in 28.4% of meningiomas. Staining rates are higher in high-grade tumors. The staining rate of PD-L1 in the tumor increased significantly with pattern loss. PD-L1 expression in immune cells is 19.9%. Immune cell expression and the number of expressing immune cells correlate with spontaneous necrosis. Immune cell expression and the number of expressing immune cells are increased in high-grade meningiomas. PD-1 expression in immune cells is 9.0%, and this correlates with brain invasion.

Conclusions

With these data, it was observed that the expression of immune checkpoint molecules PD-L1, PD-1 increased especially in high-grade meningiomas. It may be the subject of research that these molecules may be targets of immunotherapy in the treatment of meningiomas.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MeningiomaB7-H1 AntigenMeningeal NeoplasmsImmunohistochemistryProgrammed Cell Death 1 ReceptorHumansMaleFemaleMiddle AgedAgedAdultBiomarkers, TumorAged, 80 and overImmunotherapyYoung Adult

Stichwörter der Autor:innen

PD-1PD-L1immune checkpointimmunotherapymeningioma

Substanzen

B7-H1 AntigenCD274 protein, humanProgrammed Cell Death 1 ReceptorPDCD1 protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Pathology, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkiye.
  • Department of Pathology, Sancaktepe Şehit Prof. Dr. İlhan Varank Training and Research Hospital, İstanbul, Turkiye.
  • Department of Oncology, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkiye.
  • Department of Neurosurgery, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkiye.
  • Department of Radiology, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkiye.

ORCID-Profile: İsmail Saygin, Emel Çakir, Seher Nazlı Kazaz, Ali Rıza Güvercin, İlker Eyüpoğlu, Müşerref Müge Ustaoğlu

Zitieren

APA

Saygin, İ., Çakir, E., Kazaz, S. N., Güvercin, A. R., Eyüpoğlu, İ., & Ustaoğlu, M. M. (2024). Investigation of the status of immune checkpoint molecules (PD-L1 and PD-1) in meningiomas by immunohistochemistry. Turkish Journal of Medical Sciences, 54(4), 735-743. https://doi.org/10.55730/1300-0144.5843

Vancouver

Saygin İ, Çakir E, Kazaz SN, Güvercin AR, Eyüpoğlu İ, Ustaoğlu MM. Investigation of the status of immune checkpoint molecules (PD-L1 and PD-1) in meningiomas by immunohistochemistry. Turkish Journal of Medical Sciences. 2024;54(4):735-743. doi:10.55730/1300-0144.5843

BibTeX
@article{Saygin2024,
  author = {Saygin, İsmail and Çakir, Emel and Kazaz, Seher Nazlı and Güvercin, Ali Rıza and Eyüpoğlu, İlker and Ustaoğlu, Müşerref Müge},
  title = {Investigation of the status of immune checkpoint molecules (PD-L1 and PD-1) in meningiomas by immunohistochemistry},
  journal = {Turkish Journal of Medical Sciences},
  year = {2024},
  volume = {54},
  number = {4},
  pages = {735--743},
  doi = {10.55730/1300-0144.5843}
}
Kostenlos starten →